Skip to main content

Table 3 Colorectal and lung cancer prevention and screening discussions and decision-making by survey and study arm

From: Primary care clinicians’ opinions before and after implementation of cancer screening and prevention clinical decision support in a clinic cluster-randomized control trial: a survey research study

  Pre-Implementation Survey Post-Implementation Survey
Survey Questions n UC
n (%)
CDS
n (%)
CDS + SDMT
n (%)
p n UC
n (%)
CDS
n (%)
CDS + SDMT
n (%)
p
Consider the last patient you saw regarding colorectal cancer screening. For each of the following six statements related to the decision-making in this consultation, please select the response that best describes your actions with this patient.
I told my patient that there are different screening options (e.g. FIT, Colonoscopy)
 Agree 152 49 (89.1) 49 (87.5) 39 (95.1) 0.838 168 56 (87.5) 45 (86.5) 47 (90.4) 0.409
 Neither   1 (1.8) 1 (1.8) 0 (0.0)    0 (0) 1 (1.9) 2 (3.9)  
 Disagree   5 (9.1) 6 (10.7) 2 (4.9)    8 (12.5) 6 (11.5) 3 (5.8)  
 Pre-post within arm pa   0.559 1.000 0.691       
I explained the advantage and disadvantages of the screening options to my patient
 Agree 152 49 (89.1) 49 (87.5) 40 (97.6) 0.489 167 56 (87.5) 45 (86.5) 46 (90.2) 0.411
 Neither   1 (1.8) 2 (3.6) 0 (0.0)    0 (0) 1 (1.9) 2 (3.9)  
 Disagree   5 (9.1) 5 (8.9) 1 (2.4)    8 (12.5) 6 (11.5) 3 (5.9)  
 Pre-post within arm pa   0.559 0.905 0.448       
I helped my patient understand all the information
 Agree 150 49 (90.7) 47 (85.5) 40 (97.6) 0.442 166 54 (87.1) 45 (86.5) 46 (88.5) 0.601
 Neither   2 (3.7) 3 (5.5) 0 (0.0)    1 (1.6) 1 (1.9) 3 (5.8)  
 Disagree   3 (5.6) 5 (9.1) 1 (2.4)    7 (11.3) 6 (11.5) 3 (5.8)  
 Pre-post within arm pa   0.440 0.688 0.284       
I asked my patient which screening option he/she prefers
 Agree 152 47 (85.5) 50 (89.3) 38 (92.7) 0.837 168 53 (82.8) 43 (82.7) 47 (90.4) 0.152
 Neither   2 (3.6) 1 (1.8) 1 (2.4)    0 (0) 2 (3.9) 2 (3.9)  
 Disagree   6 (10.9) 5 (8.9) 2 (4.9)    11 (17.2) 7 (13.5) 3 (5.8)  
 Pre-post within arm pa   0.206 0.583 1.000       
My patient and I selected a screening option together
 Agree 150 43 (78.2) 49 (87.5) 38 (97.4) 0.054 168 53 (82.8) 45 (86.5) 46 (88.5) 0.302
 Neither   7 (12.7) 2 (3.6) 0 (0.0)    0 (0) 1 (1.9) 2 (3.9)  
 Disagree   5 (9.1) 5 (8.9) 1 (2.6)    11 (17.2) 6 (11.5) 4 (7.7)  
 Pre-post within arm pa   0.005 0.905 0.383       
My patient and I reached an agreement on how to proceed
 Agree 150 46 (83.6) 46 (85.2) 38 (92.7) 0.522 167 54 (85.7) 45 (86.5) 47 (90.4) 0.324
 Neither   5 (9.1) 2 (3.7) 1 (2.4)    0 (0) 1 (1.9) 2 (3.8)  
 Disagree   4 (7.3) 6 (11.1) 2 (4.9)    9 (14.3) 6 (11.5) 3 (5.8)  
 Pre-post within arm pa   0.025 1.000 1.000       
Consider the last patient you saw who was a possible candidate for lung cancer screening. For each of the following two statements related to the decision-making in this consultation, please select the response that best describes your actions with this patient.
I helped my patient understand all the risks and benefits and details about screening
 Agree 146 37 (69.8) 35 (64.8) 28 (71.8) 0.665 165 53 (84.1) 40 (78.4) 43 (84.3) 0.030
 Neither   6 (11.3) 11 (20.4) 4 (10.3)    2 (3.2) 9 (17.7) 2 (3.9)  
 Disagree   10 (18.9) 8 (14.8) 7 (18.0)    8 (12.7) 2 (3.9) 6 (11.8)  
 Pre-post within arm pa   0.122 0.136 0.305       
My patient and I reached an agreement on how to proceed
 Agree 142 37 (69.8) 34 (65.4) 26 (70.3) 0.957 159 50 (84.8) 39 (79.6) 44 (86.3) 0.002
 Neither   9 (17.0) 10 (19.2) 5 (13.5)    1 (1.7) 9 (18.4) 1 (2.0)  
 Disagree   7 (13.2) 8 (15.4) 6 (16.2)    8 (13.6) 1 (2.0) 6 (11.8)  
 Pre-post within arm pa   0.015 0.060 0.076       
  1. Note. Freeman-Halton Exact Test. CDS Clinical Decision Support, SDMT Shared Decision-Making Tool, UC Usual Care
  2. aComparing pre- and post-implementation survey responses within study arms